The data indicate that chemically synthesized citrate-AuNPs suppress the expression of SOCS1 by modulating hsa-miR155-5p and deactivating the activity of NF-κB p65/p50 in triple-negative breast cancer cells. Here, SOCS1 is linked to triple-negative breast carcinoma.